Some review and maybe something new.
Recent research on fluid biomarkers in multiple sclerosis (MS) frames an emerging picture of two aspects of the disease: inflammatory activity measured with neurofilament light chain (NfL), and disease progression independent of relapses, with promising results suggested by emerging markers like glial fibrillary acidic protein (GFAP).
multiple sclerosis
Multiple Sclerosis Social Effects
HEALTH NEWSNew Drug Shows Promise in Treating Secondary Progressive Multiple Sclerosis
